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Abstract Low concentrations of serum or interstitial fluid have
been shown to inhibit the oxidation of low density lipoprotein
(LDL) catalysed by copper or iron, and may therefore protect
against the development of atherosclerosis. As atherosclerotic
lesions may have an acidic extracellular pH, we have investigated
the effect of pH on the inhibition of LDL oxidation by serum and
certain components of serum. Human serum (0.5%, v/v),
lipoprotein-deficient human serum at an equivalent concentration
and the amino acids L-cysteine (25 WM) and L-histidine (25 WM),
but not L-alanine (25 WM), inhibited effectively the oxidation of
LDL by copper at pH 7.4, as measured by the formation of
conjugated dienes. The antioxidant protection was reduced
considerably at pH 6.5, and was decreased further at pH 6.0.
These observations may help to explain why LDL becomes
oxidised locally in atherosclerotic lesions in the presence of the
strong antioxidant protection offered by extracellular fluid.
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1. Introduction
Oxidised low density lipoprotein (LDL) may be involved in
the pathogenesis of atherosclerosis in numerous ways [1,2].
Serum is a potent antioxidant and can protect LDL against
oxidation by macrophages [3,4]. Albumin, the most abundant
plasma protein, also inhibits LDL oxidation [5]. Amino acids,
for example, cysteine [6^9] and histidine [10], can also protect
LDL against oxidation. Plasma may thus protect LDL from
oxidation in the circulation and this may help to explain why
extensively oxidised LDL is probably not formed in the
bloodstream. Dabbagh and Frei [4] reported the presence of
signi¢cant concentrations of antioxidants within suction blis-
ter interstitial £uid (which is considered analogous to normal
interstitial £uid) from humans and this £uid inhibited LDL
oxidation catalysed by iron or copper e¡ectively. Evidence
does exist, however, for the presence of oxidised LDL within
atherosclerotic lesions [11].
Atherosclerotic lesions may have an acidic extracellular pH
[12,13]. These lesions show similarities to in£ammatory sites,
and in£ammatory sites are known to have a decreased extra-
cellular pH [14]. The deeper layers of the arterial wall are
ischaemic [15] and anaerobic glycolysis may therefore be re-
quired for energy production with the resultant generation of
lactic acid. Smith [16] has calculated that signi¢cant produc-
tion of lactic acid may occur within the deeper regions of the
human aortic intima and this may contribute to a localised
lactic acidosis. Macrophages in atherosclerotic lesions are in a
state of partial activation [17] and activated macrophages in
vitro are capable of acidifying their immediate environment to
a pH as low as 3.6 [18].
In this study, we have investigated the e¡ect of pH on the
antioxidant activity towards LDL oxidation of whole serum
and lipoprotein-de¢cient serum and of cysteine, histidine and
alanine, as examples of the components of extracellular £uids.
All the antioxidant activities (except of alanine) were dimin-
ished substantially at acidic pH. This may help to explain why
LDL oxidation occurs in atherosclerotic lesions in the pres-
ence of the presumably substantial antioxidant activity of the
interstitial £uid of these lesions.
2. Materials and methods
2.1. LDL isolation
LDL (1.019^1.063 g/ml) was isolated in the presence of EDTA by
sequential density ultracentrifugation from blood donated by healthy
volunteers, as described previously [19], and stored aseptically at 4‡C
for up to 4 weeks in 140 mM NaCl, 1.9 mM NaH2PO4, 8.1 mM
Na2HPO4 and 100 WM EDTA-Na2, pH 7.4.
2.2. Preparation of serum and lipoprotein-de¢cient serum
Blood from healthy volunteers was allowed to coagulate and form a
blood clot at room temperature. The blood was then centrifuged at
4‡C for 15 min at 250Ug and the serum was removed and recentri-
fuged at 4‡C for a further 10 min at 250Ug, to remove any remaining
fragments of the clot.
Liposorb (Calbiochem-Novabiochem, Nottingham, UK) was used
to prepare lipoprotein-de¢cient serum. 12.5 ml of 150 mM NaCl (pH
7.4) was added to 1 g of dry Liposorb and allowed to equilibrate and
swell for 15 min. The mixture was then boiled brie£y for 10 s at full
power in a 600 W microwave oven, to form larger aggregates, and
allowed to settle. Prior to use the Liposorb was centrifuged at 9447Ug
for 10 min to remove any excess £uid.
Serum (250 Wl) was incubated with Liposorb (250 mg wet weight) at
4‡C overnight to remove all the lipoproteins. It was then centrifuged
at 9447Ug for 10 min and the supernatant was recentrifuged under
the same conditions to remove all the Liposorb. Agarose gel electro-
phoresis (Paragon Gels, Beckman, USA) showed the treatment re-
moved the lipoprotein bands seen in whole serum. All the cholesterol
was removed from the serum, as measured by a cholesterol kit (Boeh-
ringer Mannheim, Lewes, East Sussex, UK). The treatment decreased
the protein content of serum by 45^50% as measured by a modi¢ed
Lowry assay [20], which was accounted for by the dilution of the
serum by the NaCl solution used to swell the Liposorb prior to use.
2.3. Measurement of conjugated dienes
LDL (50 Wg protein/ml) was incubated in quartz cuvettes (1 cm
light path) at 37‡C with CuSO4 (5 WM above the ¢nal concentration
of EDTA carried over from the LDL preparation, which was less than
1 WM) in modi¢ed Hanks’ balanced salt solution (HBSS). HBSS was
prepared from 5 mM H3PO4, 113 mM NaCl, 5.36 mM KCl, 0.81 mM
MgSO4 and 1.26 mM CaCl2 and adjusted to pH 7.4, 6.5 or 6 with
NaOH in the presence of Chelex-100 (1 g/l) (Sigma; pre-washed with
distilled water to remove any antioxidant [21]), to remove any con-
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taminating transition metal ions. Freshly dissolved L-cysteine, L-histi-
dine or L-alanine (Sigma) was added (to give a ¢nal concentration of
25 WM), where appropriate. The absorbance at 234 nm was recorded
in a Perkin-Elmer Lambda 2 split beam UV/visible spectrophotometer
at regular intervals, as a measure of the accumulation of conjugated
dienes [22].
The formation of conjugated dienes in LDL in the presence of
serum or lipoprotein-de¢cient serum was recorded at 245 nm, as de-
scribed by Schnitzer et al. [23]. Serum and lipoprotein-de¢cient serum
have a substantial absorbance at 234 nm, but the ratio of absorbance
due to these and that due to conjugated dienes is considerably less at
245 nm than at 234 nm [23]. The addition of serum, cysteine, histidine
or alanine at the above concentrations did not a¡ect the pH of the
bu¡ers at pH 7.4, 6.5 or 6.0.
Reference cuvettes were prepared in the same manner as the test
cuvettes, but without LDL, and their absorbance was automatically
subtracted by the spectrophotometer from that of the test cuvettes.
The lag period was taken as the intercept between the tangent to the
curve during the propagation phase of lipid peroxidation and the
abscissa. The rate of propagation of lipid peroxidation was calculated
as the gradient of the tangent to the curve during the propagation
phase [22].
3. Results
3.1. The e¡ect of pH on LDL oxidation by copper
LDL oxidation by copper, monitored by following the for-
mation of conjugated dienes, exhibited the typical pattern
described by Esterbauer et al. [22], with a lag phase, a prop-
agation phase in which the conjugated dienes increased rap-
idly and a decomposition phase (Fig. 1). Decreasing the pH
from 7.4 to 6.5 or 6.0 increased progressively the length of the
lag phase and decreased progressively the rate of propagation
(Fig. 1 and Table 1). The maximum levels of conjugated di-
enes were similar at the various pH values.
3.2. E¡ect of pH on the inhibition of LDL oxidation by serum
A low concentration (0.5%, v/v) of normal human serum
protected LDL e¡ectively from oxidation by copper at pH 7.4
(Fig. 1 and Table 1). There was an initial increase in A245 in
the presence of serum, which continued to increase at a lower
rate prior to the rapid increase in conjugated dienes character-
istic of the propagation phase. A similar pattern has been
observed in the presence of albumin [23]. The lag phase before
the propagation phase was increased over 10-fold and the rate
of propagation was inhibited by 85% by serum. The antiox-
idant e¡ect of the serum was less at pH 6.5 than at pH 7.4. At
pH 6.5, the increase in the lag phase due to serum was 3.8-
fold, and the rate of the propagation phase was decreased less
than at pH 7.4. Decreasing the pH to 6.0 resulted in an addi-
tional decrease in the antioxidant e¡ect of the serum, the lag
phase being increased by only 1.8-fold. The lag phase in the
presence of serum was decreased and the rate of propagation
was increased as the pH was lowered, reversing the pattern
observed in the absence of serum.
We also investigated the e¡ect of pH and lipoprotein-de¢-
cient serum on the oxidation of LDL, as serum would contain
lipoproteins (albeit at low concentrations in 0.5% (v/v) serum).
We used a concentration of 1% (v/v) of lipoprotein-de¢cient
serum because, as described in the methods section, the pro-
tein concentration was reduced by 45^50% by the Liposorb
used to remove the serum lipoproteins (probably due to the
dilution of the serum proteins by the NaCl solution used to
swell the Liposorb powder). The serum and lipoprotein-de¢-
cient serum would therefore have been used at about the same
protein concentration. Lipoprotein-de¢cient serum inhibited
LDL oxidation, but the inhibition was less at acidic pH
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Fig. 1. E¡ect of pH and serum on LDL oxidation by copper ions
as measured by conjugated dienes. LDL (50 Wg protein/ml) was oxi-
dised at 37‡C in modi¢ed HBSS of various pH values in the pres-
ence of CuSO4 (5 WM net), with (¢lled symbols) or without (open
symbols) serum (0.5%, v/v). The absorbance at 245 nm was moni-
tored against appropriate reference cuvettes without LDL every
2 min. The results shown are representative of ¢ve independent
experiments.
Table 1
The change in lag time, propagation rate and maximum increase in conjugated dienes in LDL oxidised by copper in the presence or absence of
serum or lipoprotein-de¢cient serum at various pH values
pH Addition of
inhibitor
Lag (min) Fold increase in lag
phase due to inhibitor
Propagation rate
(change in A245/min)
Decrease in propagation
rate with inhibitor (%)
Max increase
in A245
7.4 No addition 10 þ 2 0.0132 þ 0.0003 0.404 þ 0.006
+Serum 107 þ 7 10.7 0.0020 þ 0.0001 85 0.410 þ 0.021
6.5 No addition 16 þ 2 0.0111 þ 0.0002 0.404 þ 0.006
+Serum 61 þ 2 3.8 0.0039 þ 0.0002 65 0.417 þ 0.014
6.0 No addition 28 þ 2 0.0085 þ 0.0004 0.391 þ 0.010
+Serum 49 þ 6 1.8 0.0047 þ 0.0004 45 0.403 þ 0.012
7.4 No addition 37 þ 2 0.0142 þ 0.0014 0.407 þ 0.011
+LPDS 70 þ 1 1.9 0.0041 þ 0.0002 71 0.420 þ 0.023
6.5 No addition 41 þ 1 0.0104 þ 0.0001 0.402 þ 0.005
+LPDS 50 þ 6 1.2 0.0063 þ 0.0003 39 0.403 þ 0.009
6.0 No addition 46 þ 2 0.0084 þ 0.0003 0.403 þ 0.011
+LPDS 45 þ 2 1.0 0.0071 þ 0.0001 15 0.433 þ 0.010
Serum was added at 0.5% (v/v) and the lipoprotein-de¢cient serum at 1% (v/v). The mean þ S.E.M. is shown for ¢ve individual experiments for
serum and three for lipoprotein-de¢cient serum (LPDS). Di¡erent batches of LDL were used for the experiments involving serum and lipoprotein-
de¢cient serum.
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than at pH 7.4 (Fig. 2 and Table 1), as was the case with
serum. In the presence of lipoprotein-de¢cient serum, the ox-
idation was faster at acidic pH than at pH 7.4.
3.3. E¡ect of pH on the inhibition of LDL oxidation by the
amino acids cysteine, histidine and alanine
Cysteine (25 WM) was an e¡ective antioxidant against LDL
oxidation by copper at pH 7.4 (Fig. 3). It resulted in about an
eight-fold increase in the duration of the lag phase and a
decrease in the rate of propagation of 77% (Table 2). At pH
6.5, cysteine increased the duration of the lag phase by only
about four-fold and decreased the rate of propagation by
56%. The inhibition by cysteine of LDL oxidation decreased
further at pH 6.0.
LDL oxidation by copper was inhibited more e¡ectively by
L-histidine (25 WM) than by an equimolar concentration of L-
cysteine (Fig. 4 and Table 2). A similar e¡ect of pH was
observed for histidine as for cysteine, in that histidine had a
lower antioxidant activity at acidic pH than at pH 7.4. The
oxidation of LDL was faster at acidic pH than at pH 7.4 in
the presence of either histidine or cysteine.
In the presence of cysteine or histidine, there was an initial
increase in A234 followed by a lower rate of increase before
the propagation phase of oxidation of LDL was reached,
which was similar to the e¡ect observed at 245 nm with
serum.
Alanine (25 WM), which lacks the functional groups of the
side chains of cysteine or histidine, increased slightly the du-
ration of the lag phase of LDL oxidation, but was a much less
e¡ective antioxidant than cysteine or histidine (Fig. 5 and
Table 2). The formation of conjugated dienes in LDL by
copper was slower at acidic pH than at pH 7.4 in the presence
or absence of alanine, unlike the case with the other two
amino acids.
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Fig. 2. E¡ect of pH and lipoprotein-de¢cient serum on LDL oxida-
tion by copper ions as measured by conjugated dienes. LDL was in-
cubated as described in Fig. 1 with or without lipoprotein-de¢cient
serum (1% v/v, an approximately equivalent protein concentration
to the serum used in Fig. 1). The results shown are representative
of three independent experiments.
Fig. 3. E¡ect of pH and L-cysteine on LDL oxidation by copper
ions as measured by conjugated dienes. LDL was incubated as de-
scribed in Fig. 1, with or without freshly dissolved 25 WM cysteine.
The absorbance at 234 nm was monitored against appropriate refer-
ence cuvettes without LDL every 5 min. The results shown are rep-
resentative of three independent experiments.
Table 2
The change in lag time, propagation rate and maximum increase in conjugated dienes of LDL oxidised by copper in the presence or absence of
L-cysteine, L-histidine or L-alanine at various pH values
pH Addition of
amino acid
Lag (min) Fold increase in lag
phase due to amino acid
Propagation rate
(change in A234/min)
Decrease in propagation
rate with amino acid (%)
Max increase
in A234
7.4 No addition 33 þ 3 0.0180 þ 0.0025 0.735 þ 0.006
+Cysteine 275 þ 33 8.3 0.0042 þ 0.0005 77 0.639 þ 0.060
6.5 No addition 43 þ 2 0.0153 þ 0.0025 0.752 þ 0.059
+Cysteine 174 þ 21 4.0 0.0068 þ 0.0013 56 0.727 þ 0.087
6.0 No addition 61 þ 6 0.0105 þ 0.0028 0.781 þ 0.054
+Cysteine 174 þ 14 2.9 0.0056 þ 0.0008 47 0.751 þ 0.024
7.4 No addition 32 þ 4 0.0220 þ 0.0019 0.770 þ 0.002
+Histidine 475 þ 83 14.7 0.0029 þ 0.0004 87 0.638 þ 0.090
6.5 No addition 37 þ 5 0.0182 þ 0.0004 0.784 þ 0.040
+Histidine 267 þ 18 7.2 0.0050 þ 0.0004 73 0.756 þ 0.037
6.0 No addition 50 þ 3 0.0144 þ 0.0003 0.775 þ 0.021
+Histidine 249 þ 29 5 0.0050 þ 0.0008 65 0.714 þ 0.085
7.4 No addition 23 þ 0.2 0.0282 þ 0.0044 0.925 þ 0.108
+Alanine 29 þ 0.3 1.3 0.0277 þ 0.0045 2 0.977 þ 0.121
6.5 No addition 33 þ 1.0 0.0209 þ 0.0024 0.820 þ 0.028
+Alanine 36 þ 1.0 1.1 0.0193 þ 0.0030 8 0.866 þ 0.098
6.0 No addition 48 þ 1.0 0.0157 þ 0.0018 0.816 þ 0.066
+Alanine 53 þ 0.6 1.1 0.0154 þ 0.0020 2 0.857 þ 0.085
The amino acids were added at a concentration of 25 WM. The mean þ S.E.M. is shown for three individual experiments using di¡erent batches of
LDL.
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4. Discussion
As expected, the early stages of LDL oxidation by copper
were slower at acidic pH than at pH 7.4, in agreement with
previously published work [8,24]. Although the earlier stages
of LDL oxidation are delayed at acidic pH, the later stages of
oxidation leading to increased uptake of LDL by macro-
phages are potentiated at acidic pH [8].
It has previously been reported [3,4] that LDL oxidation is
inhibited potently by serum in vitro, and the results presented
here agree with this ¢nding. A low concentration of serum or
lipoprotein-de¢cient serum e¡ectively delayed the onset of
LDL oxidation by copper at pH 7.4. Cysteine (25 WM), at a
near plasma concentration (33 WM) [25], also inhibited e¡ec-
tively the oxidation of LDL by copper, in agreement with
previous ¢ndings [6^9]. Histidine is an e¡ective chelator of
copper (log stability constant 10.2 [26]) and at a concentration
(25 WM) much below its plasma level (which is about 90 WM
[25]) was an excellent antioxidant for LDL at pH 7.4 in this
study.
In the presence of serum, cysteine or histidine, there was an
initial increase in the A245 or A234 of LDL incubated with
copper. The rate of oxidation then became less but the oxi-
dation continued to increase slowly until the rate of oxidation
increased rapidly during the propagation phase. Similar ob-
servations have been described previously for albumin [23]
and the initial increase in oxidation ascribed to tocopherol-
mediated peroxidation [23,27].
Alanine was included in this study to show that the anti-
oxidant e¡ect of cysteine and histidine involved the side
chains of these amino acids. Alanine, with simply a methyl
group as a side chain, was a poor antioxidant compared to
cysteine, which has a methylene and thiol group as a side
chain, and histidine, which has a methylene and imidazole
group as its side chain.
The antioxidant protection provided by whole serum, lipo-
protein-de¢cient serum, cysteine and histidine was decreased
considerably at acidic pH. In the absence of these antioxi-
dants, the formation of conjugated dienes in LDL incubated
with copper was slower at acidic pH, whereas in their presence
the formation of the conjugated dienes was faster at acidic
pH.
We propose that an acidic pH decreases the binding of
copper to these antioxidants. The amount of copper available
to catalyse LDL oxidation would therefore be increased at
acidic pH. Less copper may bind to proteins, cysteine (or
more likely, its oxidation products) or histidine at acidic
pH, due to the protonation of the residues involved in copper
binding. The imidazole group of histidine (as the free amino
acid) has a pKa of 6.0 and the Henderson-Hasselbach equa-
tion predicts that at pH 7.4 only about 4% of these groups
would be present in the protonated form, whereas at pH 6.5
this increases to 24%, and at pH 6.0 to 50%. (It should be
noted, however, that the pKa values of the ionisable groups
may be a¡ected by their binding of copper.) The result of the
protonation of such amino acids may be to decrease copper
binding to them, due to electrostatic repulsion, and conse-
quently more copper may be available to oxidise LDL. The
thiol group of cysteine has a pKa of 8.35 and if the negatively
charged thiolate form were to bind copper ions more avidly
than does the non-dissociated form, an acidic pH would be
expected to decrease the binding of copper to cysteine. The
thiol group of cysteine is rapidly oxidised by copper [28],
however, and so this consideration may not apply. The e¡ect
of pH on the binding of copper to the oxidation products of
cysteine is unclear.
In conclusion, atherosclerotic lesions may possibly have an
acidic extracellular pH [13] and the decreased antioxidant
protection at acidic pH by components of the interstitial £uid
of these lesions may help to explain why LDL oxidation oc-
curs at these sites.
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